News

Special Sections

Epizyme Gets Accelerated FDA Approval of Epithelioid Sarcoma Drug

Epizyme Gets Accelerated FDA Approval of Epithelioid Sarcoma Drug

Edward Kim | Equities.com |

First epithelioid sarcoma treatment approved by the FDA.


Absent Iran Faces Detente Calls From Worried West and Middle East

Reuters | Equities.com |

Iranian Foreign minister Javad Zarif skipped Davos this year, but Iran was still a hot topic.


Case Western Researchers Identify New Gene With Potential Alzheimer's Link

Edward Kim | Equities.com |

Researchers say they have identified a previously unknown gene and associated protein that could potentially be suppressed to slow the advance of Alzheimer's.


Akcea and Ionis Report Positive Phase 2 Results in Hypertriglyceridemia

Edward Kim | Equities.com |

More than 90% of patients achieved serum triglycerides ≤ 150 mg/dL at the highest monthly dose.


The Return of Lithium in 2020

Gary C. Bizzo | Equities.com |

An update on One World Lithium operations in Mexico


J&J Forecasts Weak Annual Profit, Misses Revenue Estimates

Reuters | Equities.com |

A rare miss on quarterly revenue as sales of some of its major drugs fall short of Wall Street expectations.


Halliburton Beats Estimates But Takes $2.2 Billion Charge on Shale Slump

Reuters | Equities.com |

Weakening North American shale activity continued to hit the industry.


International Energy Agency Sees 1 Million Barrels Per Day Oil Surplus in First Half 2020

Reuters | Equities.com |

Prices are not expected to rise significantly under “normal conditions” although unexpected developments, such as rising instability in Iraq, could alter the situation.


AstraZeneca Gets Orphan Drug Designation on Two Liver Cancer Therapy Assets

Edward Kim | Equities.com |

IMFINZI and tremelimumab are checkpoint inhibitors being investigated in the most common form of liver cancer.


I-Mab Biopharma Raises $104 Million in Nasdaq IPO

Edward Kim | Equities.com |

First Chinese biotech company to go public in the US since September 2017.


Humanity. 2.0 - Opening Address at the Vatican

The opening address was delivered by Rev. Philip Larrey, Chairman of. Humanity 2.0, and Matthew. Sanders, CEO & Founder of Humanity 2.0.


Events

Sohn Investment Conference

Wall Street’s best and brightest investors participate in this unique, “must attend” event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset…

Learn more